Michael Julian Humphreys - 11 Oct 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol
TGAN
Transactions as of
11 Oct 2023
Transactions value $
$0
Form type
4
Filing time
13 Oct 2023, 16:22:30 UTC
Previous filing
25 Jul 2023
Next filing
24 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +45.7K +124.5% $0.00 82.3K 11 Oct 2023 Direct F1
transaction TGAN Common Stock Award $0 +3.08K +3.74% $0.00 85.4K 11 Oct 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). One-fourth (1/4) of the RSUs will vest on each of November 20, 2023, February 20, 2024, May 20, 2024 and the earlier of August 20, 2024 or the day prior to the date of Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as of each such vesting date.
F2 Each share is represented by an RSU. The RSUs were fully vested as of the grant date. The shares were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended June 30, 2023.